Cidel Asset Management Inc Astrazeneca PLC Transaction History
Cidel Asset Management Inc
- $1.56 Billion
- Q3 2025
A detailed history of Cidel Asset Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Cidel Asset Management Inc holds 598,309 shares of AZN stock, worth $53.5 Million. This represents 2.94% of its overall portfolio holdings.
Number of Shares
598,309
Previous 599,997
0.28%
Holding current value
$53.5 Million
Previous $41.9 Million
9.48%
% of portfolio
2.94%
Previous 2.81%
Shares
32 transactions
Others Institutions Holding AZN
# of Institutions
1,499Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...